![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Healthcare Enterprise Group PLC 01 March 2005 Ebiox surface disinfectant, test results Proven combatant ability against HIV and Avian Flu Healthcare Enterprise Group PLC ("HCEG"), the international healthcare products and Services Company announces that its TrionicTM product, from the Ebiox family of products, has passed tests proving virucidal efficacy against the HIV and Avian Flu ( Bird Flu) viruses. The tests, conducted by Microbiotest Inc of Sterling, Virginia, USA conclude that using Trionic in a range of different levels of dilution, applicable to the test, the two viruses became undetectable. Reports this week surrounding the failure to reduce death rates from MRSA in the UK and the need to remain vigilant with HIV, highlighted once again the need to improve hygiene practices on our own doorstep. However, the problem of cross contamination is much more widespread as evidenced by the growing fear surrounding the spread of Avian Flu around the world. According to the World Health Organisation, Avian Flu viruses can be readily transmitted from farm to farm by mechanical means, such as contaminated equipment, vehicles and cages. Stringent sanitary measures on farms can confer some degree of protection, including hand hygiene and surface cleaning and disinfection. HCEG recently completed agreement with Alpha Trading (Asia) Co Ltd covering the distribution of Ebiox throughout Asia and reports encouraging initial demand driven by the Avian Flu crisis. TrionicTM is a highly effective disinfectant already proven to combat MRSA, SARS and other pathogens. The product offers significant safety advantages over all other commonly used disinfectants and does not contain alcohol, chlorine or other irritating vapours. Moreover, TrionicTM contains soil lifting agents and biocides, which allow removal of microbes down to the molecular level, by removing biofilms, which are believed to provide a rich breeding ground for the development of resistant bacteria. Many of the disinfectants currently used are ineffective in dirty conditions, when soiling is present. TrionicTM works differently, cleaning, disinfecting and deodorising in one to provide complete decontamination. Stuart Bruck, Chairman, Healthcare Enterprise Group PLC, commented: "Avian Flu has been described as the number one health threat in the world and huge resources are being channelled at controlling the disease which has a 76% fatality rate. As with HIV, MRSA, SARS and all other deadly diseases, the microbes can harbour on surface areas, hence the need to regularly decontaminate. TrionicTM, through its unique properties, eradicates all surface microbes and pathogens without the problem of resistant strains forming. "We plan to market TrionicTM aggressively across all relevant industry sectors internationally, thus affording rapid deployment to combat this serious international problem." 1 March 2005 Enquiries: Healthcare Enterprise Group 020 7351 7500 Stuart Bruck Executive Chairman Gordon Wood Group Chief Operating Officer College Hill 020 7457 2020 Nicholas Nelson Corinna Dorward Note to editors Ebiox Ebiox produces a range of patented cleansing, decontamination and disinfectant products. The range includes hand hygiene products, environmental disinfectants and products to clean and decontaminate surgical instruments. The antibacterial handwash and handrub, are proven effective against MRSA, E-coli and other important pathogens and are fully compliant with EU standards. Uniquely, the products do not use alcohol, which has a drying effect and can be a skin irritant. The environmental disinfectant range including Trionic spray and wipes, lift and remove dirt and bacteria, completely removing biofilms and cleaning to the molecular level. The product cleans through oxidation , not toxification which means that there is no need to rotate disinfectants because there is no chance of resistance developing (cf GMP guidelines). Ebiox also offers a range of products for the effective cleaning of re-usable instruments. Critically, these products remove all debris prior to the sterilisation process thereby ensuring complete decontamination. They have proven to be more effective than natural detergents and enzymatic detergents currently available. As well as the current range of products, Ebiox also has products for the decontamination of dental water lines and a veterinary product range, EbioxVET. Healthcare Enterprise Group PLC HCEG is quoted on the UK AIM stock market with its head office in London. HCEG is a business engaged in medical product distribution, occupational health, first aid and medical consultancy markets. These businesses underpin a range of innovative medical devices, which will be introduced to the market via HCEG's own distribution network on an international basis. This information is provided by RNS The company news service from the London Stock Exchange END NRAPKDKQFBKKCNK
1 Year Healthcare Enterprise Chart |
1 Month Healthcare Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions